Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Fall on the Road
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Techne Cp
(NQ:
TECH
)
71.88
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
71.88
Bid (Size)
49.80 (1)
Ask (Size)
115.00 (2)
Prev. Close
71.88
Today's Range
71.88 - 71.88
52wk Range
51.79 - 89.91
Shares Outstanding
157,191,685
Dividend Yield
0.45%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.
Via
InvestorPlace
Bio-Techne: Commitment to Investor Contentment with Steadfast Earnings Performance
March 07, 2024
Via
Benzinga
Performance
YTD
-6.30%
-6.30%
1 Month
+2.20%
+2.20%
3 Month
-5.45%
-5.45%
6 Month
+1.00%
+1.00%
1 Year
-0.94%
-0.94%
More News
Read More
Bio-Techne: Bolstering Investor Value with Reduced Dividends and Amplified Earnings
February 26, 2024
Via
Benzinga
The 3 Best Biotech Stocks to Buy in February 2024
February 13, 2024
Via
InvestorPlace
RBC Capital Maintains Sector Perform Rating for Bio-Techne: Here's What You Need To Know
February 02, 2024
Via
Benzinga
3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024
January 21, 2024
Via
InvestorPlace
Expert Ratings for Bio-Techne
December 07, 2023
Via
Benzinga
Earnings Preview: Bio-Techne
October 30, 2023
Via
Benzinga
Bio-Techne's Ex-Dividend Date Is Thursday, Here's What You Need To Know
August 14, 2023
Via
Benzinga
Earnings Scheduled For February 1, 2024
February 01, 2024
Via
Benzinga
Earnings Outlook For Bio-Techne
January 31, 2024
Via
Benzinga
Advancing with Stability: Bio-Techne Benefits Investors with Growing Earnings and Stable Payouts
November 24, 2023
Via
Benzinga
Earnings Scheduled For October 31, 2023
October 31, 2023
Via
Benzinga
Nurturing Growth: Bio-Techne Supports Investors with Growing Earnings
August 08, 2023
Via
Benzinga
This Favorable Sign Appears On Bio-Techne's Chart
May 31, 2023
Via
Benzinga
3 AI Stock-Split Stocks to Buy Now
October 25, 2023
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Healthcare Stocks to Keep an Eye On
October 03, 2023
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
Via
Benzinga
3 Healthcare Stocks That Should Be on Every Investor’s Radar This Fall
September 23, 2023
Via
InvestorPlace
Life Science Firm Bio-Techne's Success Formula: Astute Acquisitions Offering Transformation
August 28, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via
Benzinga
3 Biotech Stocks to Buy Before the Breakout
July 28, 2023
Via
InvestorPlace
Bio-Techne's Acquisition of Lunaphore Expands Its Spatial Biology Offerings
June 22, 2023
Via
Benzinga
Lunaphore to Get Acquired by Bio-Techne
June 22, 2023
From
Lunaphore
Via
Business Wire
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
June 20, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.